World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01218815
Date of registration: 01/10/2010
Primary sponsor: Fundacja Osrodek Badan Medycznych
Public title: Complete Infarct Related Artery Revascularization CORAMI
Scientific title: Complete Infarct Related Artery Revascularization in Acute Myocardial Infarction Patients - CORAMI Trial
Date of first enrolment: October 2010
Target sample size: 1
Recruitment status: Terminated
URL:  http://clinicaltrials.gov/show/NCT01218815
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Countries of recruitment
Poland Slovenia
Contacts
Name:   Dariusz Dudek, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Department of Interventional Cardiology, Jagiellonian University Medical College in Krakow, Poland
Key inclusion & exclusion criteria

Inclusion Criteria:

- diagnosis of STEMI (according to ESC 2007 definition)

- Chest pain onset <12 hours

- signed informed consent

- Presence of two critical lesions requiring PCI in IRA (LAD - left anterior
descending, Cx - circumflex, RCA - right coronary artery)

- Target/culprit lesion which requires immediate stenting (>50 - 100%) and second
critical lesion (70-90%) with TIMI 3 flow after PCI of the 1st target/culprit lesion

- Over 18 years of age

- IRA diameter = 2.5 mm

Exclusion Criteria:

- Terminal illness with life expectancy less <1 year or active cancer disease -
Pregnancy or possibility of pregnancy

- Second critical lesion in IRA >90% or occlusion

- Contraindications to PCI or/and stent implantation

- Contraindications to DES stent implantation

- Lesion diameters unsuitable for intended stent platform

- Active bleeding or coagulopathy

- Patient in cardiogenic shock (<90mmHg SBP and/or requiring IABP - intraaortic balloon
pump - or vasopressors) - Killip 4 class

- Patient has Left Bundle Branch Block (LBBB) or pacemaker rhythm

- No future patient cooperation expected

- Patient is participating in another clinical study



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Coronary Artery Disease
Myocardial Infarction
Intervention(s)
Procedure: IRA stenting
Procedure: IRA stenting in culprit lesion only
Primary Outcome(s)
ST resolution in ECG (electrocardiogram) and MBG (myocardial blush grade) [Time Frame: in-hospital directly after PCI]
Secondary Outcome(s)
Adverse events and complications during hospital stay [Time Frame: during patient index hospitalization (up to 7 days)]
Clinical major ischemic events [Time Frame: 12-months]
Secondary ID(s)
3.0/2010
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history